English | Español
Patient Daily | Feb 22, 2026

Study finds pancreatic tumor environment influences cell survival and therapy resistance
Patient Daily | Feb 22, 2026

Inflammation’s complex role informs new personalized strategies against cancer
Patient Daily | Feb 22, 2026

MHRA consults on indefinite CE mark recognition for medical devices
Patient Daily | Feb 22, 2026

QuantalX launches Delphi-MD system in U.S. after FDA De Novo clearance
Patient Daily | Feb 22, 2026

FDA’s shift from animal testing highlights role of AI and organoids in drug development
Patient Daily | Feb 22, 2026

Mount Sinai-led study develops AI tool to assess heart risks after tetralogy of Fallot repair
Patient Daily | Feb 22, 2026

New technique reveals detailed map of protein production across mouse brain cells
Patient Daily | Feb 22, 2026

Screen-detected stage IV breast cancers linked to higher ten-year survival rates

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'